180 related articles for article (PubMed ID: 12070669)
1. Extracellular matrix and the blood-brain barrier in glioblastoma multiforme: spatial segregation of tenascin and agrin.
Rascher G; Fischmann A; Kröger S; Duffner F; Grote EH; Wolburg H
Acta Neuropathol; 2002 Jul; 104(1):85-91. PubMed ID: 12070669
[TBL] [Abstract][Full Text] [Related]
2. Localization of claudin-3 in tight junctions of the blood-brain barrier is selectively lost during experimental autoimmune encephalomyelitis and human glioblastoma multiforme.
Wolburg H; Wolburg-Buchholz K; Kraus J; Rascher-Eggstein G; Liebner S; Hamm S; Duffner F; Grote EH; Risau W; Engelhardt B
Acta Neuropathol; 2003 Jun; 105(6):586-92. PubMed ID: 12734665
[TBL] [Abstract][Full Text] [Related]
3. Endothelial cell barrier impairment induced by glioblastomas and transforming growth factor beta2 involves matrix metalloproteinases and tight junction proteins.
Ishihara H; Kubota H; Lindberg RL; Leppert D; Gloor SM; Errede M; Virgintino D; Fontana A; Yonekawa Y; Frei K
J Neuropathol Exp Neurol; 2008 May; 67(5):435-48. PubMed ID: 18431253
[TBL] [Abstract][Full Text] [Related]
4. Molecular markers of extracellular matrix remodeling in glioblastoma vessels: microarray study of laser-captured glioblastoma vessels.
Pen A; Moreno MJ; Martin J; Stanimirovic DB
Glia; 2007 Apr; 55(6):559-72. PubMed ID: 17266141
[TBL] [Abstract][Full Text] [Related]
5. Redistribution of aquaporin-4 in human glioblastoma correlates with loss of agrin immunoreactivity from brain capillary basal laminae.
Warth A; Kröger S; Wolburg H
Acta Neuropathol; 2004 Apr; 107(4):311-8. PubMed ID: 14735305
[TBL] [Abstract][Full Text] [Related]
6. Agrin accumulates in the brain microvascular basal lamina during development of the blood-brain barrier.
Barber AJ; Lieth E
Dev Dyn; 1997 Jan; 208(1):62-74. PubMed ID: 8989521
[TBL] [Abstract][Full Text] [Related]
7. Severe alterations of endothelial and glial cells in the blood-brain barrier of dystrophic mdx mice.
Nico B; Frigeri A; Nicchia GP; Corsi P; Ribatti D; Quondamatteo F; Herken R; Girolamo F; Marzullo A; Svelto M; Roncali L
Glia; 2003 May; 42(3):235-51. PubMed ID: 12673830
[TBL] [Abstract][Full Text] [Related]
8. Expression of tenascin-C in various human brain tumors and its relevance for survival in patients with astrocytoma.
Leins A; Riva P; Lindstedt R; Davidoff MS; Mehraein P; Weis S
Cancer; 2003 Dec; 98(11):2430-9. PubMed ID: 14635078
[TBL] [Abstract][Full Text] [Related]
9. Increased caveolin-1 expression precedes decreased expression of occludin and claudin-5 during blood-brain barrier breakdown.
Nag S; Venugopalan R; Stewart DJ
Acta Neuropathol; 2007 Nov; 114(5):459-69. PubMed ID: 17687559
[TBL] [Abstract][Full Text] [Related]
10. Bradykinin increases blood-tumor barrier permeability by down-regulating the expression levels of ZO-1, occludin, and claudin-5 and rearranging actin cytoskeleton.
Liu LB; Xue YX; Liu YH; Wang YB
J Neurosci Res; 2008 Apr; 86(5):1153-68. PubMed ID: 18183615
[TBL] [Abstract][Full Text] [Related]
11. Protein components of the blood-brain barrier (BBB) in the mediobasal hypothalamus.
Norsted E; Gömüç B; Meister B
J Chem Neuroanat; 2008 Oct; 36(2):107-21. PubMed ID: 18602987
[TBL] [Abstract][Full Text] [Related]
12. Identification of extracellular matrix ligands for the heparan sulfate proteoglycan agrin.
Cotman SL; Halfter W; Cole GJ
Exp Cell Res; 1999 May; 249(1):54-64. PubMed ID: 10328953
[TBL] [Abstract][Full Text] [Related]
13. Possible involvement of gap junctions in the barrier function of tight junctions of brain and lung endothelial cells.
Nagasawa K; Chiba H; Fujita H; Kojima T; Saito T; Endo T; Sawada N
J Cell Physiol; 2006 Jul; 208(1):123-32. PubMed ID: 16547974
[TBL] [Abstract][Full Text] [Related]
14. Dynamics of expression patterns of AQP4, dystroglycan, agrin and matrix metalloproteinases in human glioblastoma.
Noell S; Wolburg-Buchholz K; Mack AF; Ritz R; Tatagiba M; Beschorner R; Wolburg H; Fallier-Becker P
Cell Tissue Res; 2012 Feb; 347(2):429-41. PubMed ID: 22307776
[TBL] [Abstract][Full Text] [Related]
15. Agrin, aquaporin-4, and astrocyte polarity as an important feature of the blood-brain barrier.
Wolburg H; Noell S; Wolburg-Buchholz K; Mack A; Fallier-Becker P
Neuroscientist; 2009 Apr; 15(2):180-93. PubMed ID: 19307424
[TBL] [Abstract][Full Text] [Related]
16. Altered expression of tight junction proteins and matrix metalloproteinases in thiamine-deficient mouse brain.
Beauchesne E; Desjardins P; Hazell AS; Butterworth RF
Neurochem Int; 2009 Sep; 55(5):275-81. PubMed ID: 19576514
[TBL] [Abstract][Full Text] [Related]
17. Post-ischemic hypothermia attenuates loss of the vascular basement membrane proteins, agrin and SPARC, and the blood-brain barrier disruption after global cerebral ischemia.
Baumann E; Preston E; Slinn J; Stanimirovic D
Brain Res; 2009 May; 1269():185-97. PubMed ID: 19285050
[TBL] [Abstract][Full Text] [Related]
18. Cadherin-10 is a novel blood-brain barrier adhesion molecule in human and mouse.
Williams MJ; Lowrie MB; Bennett JP; Firth JA; Clark P
Brain Res; 2005 Oct; 1058(1-2):62-72. PubMed ID: 16181616
[TBL] [Abstract][Full Text] [Related]
19. A new blood-brain barrier model using primary rat brain endothelial cells, pericytes and astrocytes.
Nakagawa S; Deli MA; Kawaguchi H; Shimizudani T; Shimono T; Kittel A; Tanaka K; Niwa M
Neurochem Int; 2009; 54(3-4):253-63. PubMed ID: 19111869
[TBL] [Abstract][Full Text] [Related]
20. Matrix metalloproteinase-3 removes agrin from synaptic basal lamina.
VanSaun M; Werle MJ
J Neurobiol; 2000 May; 43(2):140-9. PubMed ID: 10770843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
